相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Indirect comparison of dabigatran, rivaroxaban, apixaban and edoxaban for the treatment of acute venous thromboembolism
Simon Mantha et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2015)
Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis
Sam Schulman et al.
CIRCULATION (2014)
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC)
Stavros V. Konstantinides et al.
EUROPEAN HEART JOURNAL (2014)
Clinical and Safety Outcomes Associated With Treatment of Acute Venous Thromboembolism A Systematic Review and Meta-analysis
Lana A. Castellucci et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta- analysis
T. van der Hulle et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
Indirect treatment comparison of new oral anticoagulants for the treatment of acute venous thromboembolism
Nayon Kang et al.
THROMBOSIS RESEARCH (2014)
Incidence of and Mortality from Venous Thromboembolism in a Real-world Population: The Q-VTE Study Cohort
Vicky Tagalakis et al.
AMERICAN JOURNAL OF MEDICINE (2013)
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
Gary H. Lyman et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
Harry R. Bueller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Oral Apixaban for the Treatment of Acute Venous Thromboembolism
Giancarlo Agnelli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies
Martin H. Prins et al.
THROMBOSIS JOURNAL (2013)
New oral anticoagulants: A view from the laboratory
Jeffrey I. Weitz
AMERICAN JOURNAL OF HEMATOLOGY (2012)
Oral Anticoagulant Therapy Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Walter Ageno et al.
CHEST (2012)
Executive Summary Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Gordon H. Guyatt et al.
CHEST (2012)
Antithrombotic Therapy for VTE Disease Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence- Based Clinical Practice Guidelines
Clive Kearon et al.
CHEST (2012)
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
Harry R. Buller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Efficacy and safety of novel oral anticoagulants for treatment of acute venous thromboembolism: direct and adjusted indirect meta-analysis of randomised controlled trials
Benjamin D. Fox et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
Treatment of venous thromboembolism - effects of different therapeutic strategies on bleeding and recurrence rates and considerations for future anticoagulant management
Bastian Hass et al.
THROMBOSIS JOURNAL (2012)
External and internal validity of open label or double-blind trials in oral anticoagulation: better, worse or just different?
J. Beyer-Westendorf et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Economic burden of venous thromboembolism: a systematic review
Andras Ruppert et al.
JOURNAL OF MEDICAL ECONOMICS (2011)
Risk Assessment of Recurrence in Patients With Unprovoked Deep Vein Thrombosis or Pulmonary Embolism The Vienna Prediction Model
Sabine Eichinger et al.
CIRCULATION (2010)
Major bleeding as a predictor of mortality in patients with venous thromboembolism: findings from the RIETE Registry
P. Prandoni et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Oral Rivaroxaban for Symptomatic Venous Thromboembolism.
Rupert Bauersachs et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Venous Thromboembolism Risk Factors for Recurrence
Tienan Zhu et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Post-thrombotic syndrome: prevalence, prognostication and need for progress
Paolo Prandoni et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism.
Sam Schulman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Economic Burden of Venous Thromboembolism in Hospitalized Patients
Paul P. Dobesh
PHARMACOTHERAPY (2009)
Efficacy and safety of the oral direct factor Xa inhibitor apixaban for symptomatic deep vein thrombosis. The Botticelli DVT dose-ranging study
H. Buller et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients
Paolo Prandoni et al.
HAEMATOLOGICA (2007)
Venous thromboembolism: disease burden, outcomes and risk factors
JA Heit
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients
S Schulman et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Predictors of recurrence after deep vein thrombosis and pulmonary embolism -: A population-based cohort study
JA Heit et al.
ARCHIVES OF INTERNAL MEDICINE (2000)